The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Chiefs Hall of Honor member Art Still is a proud foot soldier in the Amyloidosis Army, a nonprofit he started hoping to ...

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most ...

Immix Biopharma (IMMX) announced that the U.S. FDA has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of ...

The European Commission has granted marketing authorization in the European Union (EU) for acoramidis, under the brand name ...

February is often celebrated as the month of love, but it's also recognized as American Heart Month, to raise awareness about cardiovascular health.

Pharma announced the European Commission has granted marketing authorization in the European Union for acoramidis, under the ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

While healthy transthyretin moves hormones through blood and spinal fluid, misfolded versions of the protein form dangerous clumps in the heart and along nerves-triggering a progressive and fatal ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...

While healthy transthyretin moves hormones through blood and spinal fluid, misfolded versions of the protein form dangerous ...